Stromedix
Biomedical company focused on drugs for fibrosis, organ failure and cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
$75m (Public information from Feb 2014)
Cambridge Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$1.0m | Series A | ||
$25.0m | Series B | ||
N/A | $2.0m | Series C | |
$75.0m Valuation: $75.0m | Acquisition | ||
Total Funding | $28.0m |